PMID: 9444331Jan 1, 1997Paper

A thymic hormone protects mice from enteropathy during acute graft-versus-host disease

Microbiology and Immunology
K Inagaki-OharaY Yoshikai

Abstract

We have previously reported that a nonapeptide thymic hormone, facteur thymique serique (FTS), is involved in the differentiation and activation of intestinal intraepithelial lymphocytes (i-IEL) in mice. In this study, we examined the effect of FTS treatment on enteropathy in a murine model for acute graft-vs.-host disease (GVHD) induced by injection of parental C57BL/6 splenocytes into unirradiated (C57BL/6 x DBA/2) F1 hybrids. FTS treatment significantly protected mice from developing acute GVHD as assessed by mortality rate, splenomegaly and enteropathy. The infiltration of donor-derived TCR alpha beta i-IEL bearing CD8 alpha beta was significantly inhibited in the small intestine of FTS-treated mice, and the frequencies of apoptosis of crypt cells in the intestinal mucosa were decreased in these mice during acute GVHD. These results suggest that FTS treatment contributes to protection against enteropathy of acute GVHD. Thus, FTS may provide a useful approach to control acute GVHD after blood transfusion or bone marrow transplantation.

References

Oct 1, 1992·Journal of Autoimmunity·B Safieh-GarabedianG R Hughes
Jan 1, 1990·Springer Seminars in Immunopathology·G J Cox, G B McDonald
Jan 1, 1987·Advances in Immunology·P J MartinE D Thomas
May 1, 1986·The Journal of Clinical Investigation·D Guy-Grand, P Vassalli
Feb 1, 1986·Gastroenterology·G B McDonaldG D Spencer
Jul 1, 1995·Immunology Today·J R Klein

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.